CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment.
Proceedings article published in 2015 by
Iannetta M. and Zingaropoli,
A. Bellizzi,
E. Anzivino,
M. Morreale,
S. Pontecorvo,
A. D’Abramo,
A. Oliva,
S. Lo Menzo,
Pietropaolo,
A. Francia,
Cm Mastroianni,
Vullo,
Mr Ciardi
